Skip to main content
Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT

Fig. 1

Comparison of [11C]C-MET to [13N]N-NH3 PET in the detection of residual PAs. Tumors were not detected by neither MRI nor [18F]F-FDG PET. [11C]C-MET and [13N]N-NH3 PET/CT images showed tumors (red arrow) and pituitary tissue (black arrow), completely differentiated by [13N]N-NH3 uptake and[11C]C-MET uptake

Back to article page